COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,941 Articles (22,604 medRxiv, 8,337 bioRxiv)

Most recent first Previous |  Page 1341: Articles 13401-13410  | Next

An Open Repository of Real-Time COVID-19 Indicators
Reinhart, A., Brooks, L., Jahja, M., Rumack, A., Tang, J., Al Saeed, W., Arnold, T., Basu, A., Bien, J., Cabrera, A. A., Chin, A., Chua, E. J., Clark, B., DeFries, N., Forlizzi, J., Gratzl, S., Green, A., Haff, G., Han, R., Hu, A. J., Hyun, S., Joshi, A., Kim, J., Kuznetsov, A., La Motte-Kerr, W., Lee, Y. J., Lee, K., Lipton, Z. C., Liu, M. X., Mackey, L., Mazaitis, K., McDonald, D. J., Narasimhan, B., Oliveira, N. L., Patil, P., Perer, A., Politsch, C. A., Rajanala, S., Rucker, D., Shah, N., Shankar, V., Sharpnack, J., Shemetov, D., Simon, N., Srivastava, V., Tan, S., Tibshirani, R., Tuzhilina, E., Van Nortwick, A. K., Ventura, V., Wasserman, L., Weiss, J. C., Williams, K., Rosenfeld, R., Tibshirani, R. J.
10.1101/2021.07.12.21259660 — Posted: 2021-07-16
Performance of antigenic detection of SARS-CoV-2 in nasopharyngeal samples
Lunca, C., Cojocaru, C., Gurzu, I. L., Petrariu, F. D., Cojocaru, E.
10.1101/2021.07.12.21260263 — Posted: 2021-07-16
The required size of cluster randomized trials of non-pharmaceutical interventions in epidemic settings
Sheen, J. K., Haushofer, J., Metcalf, C. J. E., Kennedy-Shaffer, L.
10.1101/2021.07.12.21260375 — Posted: 2021-07-16
Convergent epitope-specific T cell responses after SARS-CoV-2 infection and vaccination
Minervina, A. A., Pogorelyy, M. V., Kirk, A. M., Allen, E. K., Allison, K. J., Lin, C.-Y., Brice, D. C., Zhu, X., Vegesana, K., Wu, G., Crawford, J. C., Schultz-Cherry, S., Estepp, J. H., McGargill, M., the SJTRC Study Team, , Wolf, J., Thomas, P. G.
10.1101/2021.07.12.21260227 — Posted: 2021-07-16 Discussion: Onsite
Homologous and Variant-Specific Memory B-Cell and Antibody Responses after SARS-CoV-2 mRNA Vaccination
Haralambieva, I. H., Monroe, J. M., Grill, D. E., Ovsyannikova, I. G., Poland, G. A., Kennedy, R. B.
10.1101/2021.07.12.21260386 — Posted: 2021-07-16
Evaluation of lymphocyte subtypes in COVID-19 patients
Rezaei, M., Marjani, M., Tabarsi, P., Moniri, A., purabdollah, M., Abtahian, Z., Kazempour Dizaji, M., Dalil Roofchayee, N., Dezfuli, N. K., Mansouri, D., Hossein-Khannazer, N., Varahram, M., Mortaz, E., Velayati, A. A.
10.1101/2021.07.12.21260382 — Posted: 2021-07-16
Estimating the effectiveness of first dose of COVID-19 vaccine against mortality in England: a quasi-experimental study
Bermingham, C., Morgan, J., Ayoubkhani, D., Glickman, M., Islam, N., Sheikh, A., Sterne, J., Walker, A. S., Nafilyan, V.
10.1101/2021.07.12.21260385 — Posted: 2021-07-16
Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study
Layan, M., Gilboa, M., Gonen, T., Goldenfeld, M., Meltzer, L., Andronico, A., Hoze, N., Cauchemez, S., Regev-Yochay, G.
10.1101/2021.07.12.21260377 — Posted: 2021-07-16 Discussion: Onsite
Global and regional prevalence and outcomes of COVID-19 in people living with HIV: A systematic review and meta-analysis
Raya, R. P., Kamila, A., Alqahtani, J. S., Hjazi, A. M., Li, A., Oyelade, T.
10.1101/2021.07.12.21260361 — Posted: 2021-07-16
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Galipeau, Y., Siragam, V., Laroche, G., Marion, E., Greig, M., McGuinty, M., Booth, R., Durocher, Y., Cuperlovic-Culf, M., Bennett, S. L., Crawley, A. M., Giguere, P., Cooper, C., Langlois, M.-A.
10.1101/2021.07.16.21260079 — Posted: 2021-07-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).